Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic risk factors for inhibitors in haemophilia A.

European journal of haematology - 1 Feb 2015

Bardi Edit, Astermark Jan

Abstract excerpt

The current most serious side effect of haemophilia treatment is inhibitor development. Significant progress has been made over the last decades to understand why this complication occurs in some patients and it seems clear that both genetic and non-genetic factors are involved. Several issues however remain to be settled. A review was undertaken to summarise some key findings regarding the current view and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Black People
Share to Cytokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VIII

Share to Gene-Environment Interaction

Share to Hemophilia A

Share to Histocompatibility Antigens Class II

Share to White People

Source

Identifiers

PMID: 25560788
DOI: 10.1111/ejh.12495

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic risk factors for inhibitors in haemophilia A.PMID 25560788Read ↗

Risk factors for inhibitor development in hemophilia A.Semantic proximity Read ↗

Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.Semantic proximity Read ↗

HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdatasetSemantic proximity Read ↗

Genetic risk factors for inhibitors to factors VIII and IX.Semantic proximity Read ↗

Molecular genetics of hemophilia A: Clinical perspectivesSemantic proximity Read ↗

Haemophilia A and haemophilia B: molecular insights.Semantic proximity Read ↗

Haemophilia A and haemophilia B: molecular insights.Semantic proximity Read ↗

Factor VIII mutations and inhibitor formation in a southern Brazilian population.Semantic proximity Read ↗

F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B.Semantic proximity Read ↗

Significance of F8 missense mutations with respect to inhibitor formation.Semantic proximity Read ↗

Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.Semantic proximity Read ↗

Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.